Company Snapshot

Read it, Learn it and Do it for your investment Needs
Home > Market > Equity > Company Snapshot
Company Snapshot
Caplin Point Laboratories Ltd
Pharmaceuticals - Indian - Formulations
BSE Code: 524742 NSE Symbol: CAPLIPOINT P/E : 46.22
ISIN Demat: INE475E01026 Div & Yield %: 0.17 EPS : 52.17
Book Value: 269.76 Market Cap (Rs. Cr.): 18,328.70 Face Value : 2

Exchange

Stock Price Details
Last Price (₹) 2,342.95
Change 80.50 (3.45%)
Best Buy (₹) 0
Best Sell (₹) 0
Today's Range 2,342.95 - 2,424.00
52-Week Range 1,502.45 - 2,424.00
Beta (1 Year) 0.94
Chart
1 Day | 5 Day | 3 Month | 1 Year | 5 Year
Index Details
BSE 500, BSE HC, BSE SmallCap
Corporate Announcements
Caplin Point Lab jumps over 20% in five days
Caplin Steriles receives USFDA approval for Foscarnet Sodium Injection
Board of Caplin Point Laboratories recommends interim dividend
Caplin Point Laboratories consolidated net profit rises 19.32% in the March 2026 quarter
Caplin Point Laboratories to convene board meeting
Caplin Point gains as arm gets USFDA nod for Calcium Gluconate Injection ANDA
Caplin receives USFDA approval for Desmopressin Acetate Injection
Caplin Point’s arm Caplin Steriles gets USFDA nod for Sodium Phosphates Injection
Caplin Point Laboratories consolidated net profit rises 17.93% in the December 2025 quarter
Caplin Point Laboratories to announce Quarterly Result
Corporate Details
Incorporation Year : 1990
Chairman : C C Paarthipan
Ownership Group : Indian Private
Sector : Pharmaceuticals
Industry : Pharmaceuticals - Indian - Formulations
Registered Office :

Caplin Point Laboratories Ltd
Ashvich Towers 3rd Floor,
No 3 Developed Plots Ind Estat,
Chennai,
Tamil Nadu - 600096,
Phone : 91-44-24968000/71148000/28156653,
Fax : 91-44-28154952
E-Mail : investor@caplinpoint.net; info@caplinpoint.net
URL : http://www.caplinpoint.net
Investor Returns
Period Date Price() Returns (%)
1Week 05-Jun-2026 2,031.45 18.70
1Month 12-May-2026 1,810.25 33.20
3Month 12-Mar-2026 1,688.60 42.80
6Month 12-Dec-2025 1,962.65 22.86
1Year 12-Jun-2025 2,114.20 14.05
Mutual Funds Holding
Scheme Name % Holding Market Value (₹.Cr)
UTI-Small Cap Fund 1.53 76.29
UTI-Large & Mid Cap Fund 1.09 65.06
UTI-Aggressive Hybrid Fund 0.90 58.36
UTI-Healthcare Fund 3.08 37.45
UTI Multi Cap Fund 1.60 31.38
Peer Groups : Pharmaceuticals - Indian - Formulations
Company Last Price() Change(%) 52Week High() 52Week Low() Market Cap()
Torrent Pharmaceuticals Ltd 4,574.95 0.11 4,714.50 3,139.50 154,837.10
Ajanta Pharma Ltd 3,129.35 -0.34 3,314.80 2,335.00 39,096.73
Gland Pharma Ltd 2,261.10 -1.93 2,395.00 1,575.00 37,299.03
Rubicon Research Ltd 1,294.35 0.52 1,371.75 571.00 21,324.46
ERIS Lifesciences Ltd 1,402.90 2.64 1,909.55 1,237.90 19,439.60